ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRXL Parexel International Corp.

88.08
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Parexel International Corp. NASDAQ:PRXL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 88.08 88.10 88.11 0 01:00:00

PAREXEL Announces Date of Third Quarter Fiscal Year 2014 Earnings Release and Conference Call

01/04/2014 2:30pm

GlobeNewswire Inc.


Parexel (NASDAQ:PRXL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Parexel Charts.

PAREXEL International Corporation (Nasdaq:PRXL) will release financial results for the Third Quarter of Fiscal Year 2014 on Tuesday, April 29, 2014 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PRNewswire website at www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Wednesday, April 30, 2014 to discuss the results. To access the webcast, visit PAREXEL's website at www.PAREXEL.com, and click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL's Third Quarter Fiscal Year 2014 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 76 locations in 50 countries around the world, and has approximately 15,100 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL, Perceptive Informatics, LIQUENT, and HERON are registered trademarks of PAREXEL International Corporation or its affiliates.

CONTACT: Jill Baker, Corporate Vice President, Investor Relations
         +1-781-434-4118
         Email: Jill.Baker@parexel.com

1 Year Parexel Chart

1 Year Parexel Chart

1 Month Parexel Chart

1 Month Parexel Chart

Your Recent History

Delayed Upgrade Clock